- Companies
- Element Science
Element Science Funding, Investors & Competitors
Element Science has raised $183M across 3 funding rounds, most recently a $146M Series C in March 2020.
Last Element Science funding round
$146M
Series C · Mar 2020
Cumulative funding Element Science raised
$183M
across 3 funding rounds
Key investors in Element Science
GV
Third Rock Ventures
Deerfield
Cormorant Asset Management
Invus
Qiming Venture Partners USA
Prospect Venture Partners
About Element Science
Element Science is a San Francisco-headquartered medical device company developing wearable defibrillators for high-risk cardiac patients. The firm launched the Jewel Patch Wearable Cardioverter Defibrillator in 2023, integrating AI algorithms for arrhythmia detection during hospital-to-home transitions. Backed by $145 million in funding, Element Science conducts trials with 5,000 patients and partners with Abbott for distribution.
Founded
2011
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Element Science Funding History
Element Science has raised a total of $183M across 3 funding rounds.
Element Science's first fundraising round was a $13M Series A in March 2014. The most recent completed round was a $146M Series C in March 2020.
Element Science funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Mar 2020 | Series C | Deerfield (lead); Qiming Venture Partners USA (lead); GV; Invus; Third Rock Ventures; Cormorant Asset Management | $146M | Element Science is a San Francisco-based health technology company developing a next-generation digital wearable platform, including the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD), targeted at high-risk cardiovascular patients transitioning from hospital to home, particularly those with elevated temporary risk of sudden cardiac death, affecting over 500,000 US patients annually. Founded in 2011 by Dr. Uday Kumar, a cardiac electrophysiologist and prior founder of iRhythm Technologies, the company combines patient-centric design, machine learning algorithms, and clinical-grade electromechanical standards to improve compliance and efficacy in monitoring and treating life-threatening arrhythmias. On March 3, 2020, Element Science raised $145.6 million in an oversubscribed Series C funding round led by Deerfield Healthcare and Qiming Venture Partners USA, with participation from new investors Cormorant Asset Management and Invus Opportunities, plus existing backers Third Rock Ventures and GV (Google Ventures). This brought the company's total funding to approximately $192.6 million across multiple rounds. The proceeds are designated to scale manufacturing, quality systems, and clinical infrastructure; complete ongoing clinical studies for the Jewel platform; and support commercialization of the Jewel Patch, initially aimed at the US market for temporary SCD risk patients, where 180,000–300,000 sudden cardiac deaths occur yearly. The platform has potential for expansion into therapeutic diagnostics, inpatient monitoring, and remote heart exacerbation diagnosis. Dr. Kumar highlighted its breakthrough potential in personalized digital healthcare for global cardiovascular markets. |
| Aug 2016 | Series B | GV; Third Rock Ventures | $25M | Element Science is a San Francisco-based health technology company developing a next-generation digital wearable platform, including the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD), focused on high-risk cardiovascular patients transitioning from hospital to home, targeting over 500,000 US patients with elevated temporary risk of lethal heart rhythms. The platform emphasizes patient-centric design, machine learning algorithms, and rigorous electromechanical standards. Founded by Uday Kumar, whose prior company iRhythm (founded 2006) raised $112m before its 2016 IPO and grew to a $2.6bn market cap, Element Science emerged from stealth with a $145.6m Series C round in 2020 led by Deerfield Healthcare and Qiming Venture Partners USA, with participation from Cormorant Asset Management, Invus Opportunities, and existing investors Third Rock Ventures and GV (Google Ventures). The targeted 2016 round involved GV and Third Rock Ventures raising $25m in equity funding, as noted in regulatory documents, with Third Rock likely involved in company creation given Kumar's entrepreneur-in-residence role there from 2012-2014 and their status as existing investors in later rounds. Third Rock Ventures, a Boston-based VC firm specializing in incubating life sciences companies, had closed its $516m Fund III around that period and Fund IV ($616m) in 2016, focusing on therapeutics, devices, diagnostics, oncology, immunology, neurology, cardiovascular, and rare diseases. The company attracted top investors due to Kumar's track record and the wearable cardiac monitor's potential in atrial fibrillation screening and management, akin to iRhythm's Verily collaboration. |
| Mar 2014 | Series A | Prospect Venture Partners; GV; Third Rock Ventures | $13M | Element Science raised $12.5M in its 2014 Series A round from Prospect Venture Partners, GV, and Third Rock Ventures. The company develops clinical-grade wearable devices, machine learning algorithms, and life-saving therapies focused on cardiac care, including the Jewel Patch Wearable Cardioverter Defibrillator for patients at risk of sudden cardiac death. |
Who has invested in Element Science?
7 investors have backed Element Science across its funding rounds, including GV, Third Rock Ventures, Deerfield, Cormorant Asset Management, Invus and Qiming Venture Partners USA.
Lead investors include Deerfield and Qiming Venture Partners USA.
Element Science Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Participant | Mar 2014 | ||
| 3 | Participant | Mar 2014 | ||
| 1 | Participant | Mar 2014 | ||
| 1 | Participant | Mar 2020 | ||
| 1 | Lead | Mar 2020 | ||
This data is available for Pro users. Sign up to see all 7 Element Science investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialElement Science Competitors
Element Science competitors include listed companies like Samsung, Johnson & Johnson, Thermo Fisher Scientific and Danaher, and private ones like MindMaze and Everly Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $243B | $67B | $1.2T | 2.4x | ||
| Publicly listed | $94B | $40B | $651B | 6.8x | ||
| Publicly listed | $45B | $11B | $243B | 6.0x | ||
| Publicly listed | $25B | $6.9B | $149B | 6.6x | ||
| Private | $8M | - | $1.5B | 187.5x | ||
| Private | - | - | $1.3B | - |
Element Science Public Comps
Element Science is still privately-owned, but its public comps include Apple, Samsung, Johnson & Johnson, Roche, Thermo Fisher Scientific, Siemens, Abbott, Danaher, Intuitive Surgical and Medtronic.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $416B | $144B | 11.9x | 10.4x | 34.2x | 29.4x | |||
| $243B | $67B | 4.4x | 2.4x | 15.8x | 4.4x | |||
| $94B | $40B | 7.2x | 6.8x | 17.0x | 18.3x | |||
| $77B | $26B | 5.0x | 4.9x | 14.6x | 12.4x | |||
| $45B | $11B | 6.3x | 6.0x | 26.8x | 23.6x | |||
| $91B | $15B | 3.0x | 2.9x | 18.1x | 15.7x | |||
| $44B | $12B | 4.6x | 4.2x | 17.4x | 15.8x | |||
| $25B | $6.9B | 7.0x | 6.6x | 24.8x | 21.1x | |||
This data is available for Pro users. Sign up to see all Element Science competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Element Science
| When was Element Science founded? | Element Science was founded in 2011. |
| Where is Element Science headquartered? | Element Science is headquartered in San Francisco, CA, United States. |
| Is Element Science publicly listed? | No, Element Science is a private, VC-backed company. |
| How much funding has Element Science raised? | Element Science has raised $183M across 3 funding rounds. |
| What was Element Science's last funding round? | Element Science's last funding round was a $146M Series C in March 2020, led by Deerfield and Qiming Venture Partners USA. |
| Who are Element Science's investors? | Element Science's investors include GV, Third Rock Ventures, Prospect Venture Partners, Invus, Qiming Venture Partners USA, Cormorant Asset Management and Deerfield. |
| Which companies are comparable to Element Science? | Companies comparable to Element Science include Samsung, Johnson & Johnson, Thermo Fisher Scientific, Danaher, MindMaze and Everly Health. |
See companies similar to Element Science
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




